Table 1:
Baseline Characteristics of patients with CLD and Warfarin Users
| Demographic and Clinical Characteristics | CLD N=14,412 |
Warfarin Users N=65,722 |
P-Value |
|---|---|---|---|
|
| |||
| Median age (years) | 58.0 | 74.0 | <0.0001 |
|
| |||
| Female Gender (%) | 3.0 | 1.6 | <0.0001 |
|
| |||
| Race (%) | <0.0001 | ||
| White | 85.5 | 89.5 | |
| African American | 11.9 | 8.6 | |
| Other | 2.6 | 1.9 | |
|
| |||
| BMI Kg/m2 (%) | <0.0001 | ||
| <18.5 | 1.7 | 1.2 | |
| 18.5– <25 | 26.6 | 21.8 | |
| 25- <30 | 34.6 | 35.0 | |
| >/= 30 | 37.1 | 42.1 | |
|
| |||
| Charlson Comorbidity Index (median) | 1.0 | 0 | <0.0001 |
|
| |||
| Alcohol Use (%) | 61.7 | 5.0 | <0.0001 |
|
| |||
| Hypertension (%) | 55.4 | 81.7 | <0.0001 |
|
| |||
| Anemia (%) | 45.3 | 23.9 | <0.0001 |
|
| |||
| Antiplatelet use (%) | 13.7 | 38.6 | <0.0001 |
|
| |||
| Platelet count (%) | |||
| <50 k/mL | 4.9 | 0.1 | |
| >/=50 k/mL | 95.1 | 99.9 | |
|
| |||
| INR (% of all INR values) | <0.0001 | ||
| </= 1.5 | 75.0 | 9.6 | |
| >1.5–2.0 | 17.3 | 15.2 | |
| >2.0–2.5 | 4.0 | 47.6 | |
| >2.5–3.0 | 1.6 | 22.5 | |
| >3.0–3.5 | 0.5 | 2.7 | |
| >3.5 | 1.7 | 2.5 | |
Abbreviations: %=percentage of patients, CLD=chronic liver disease, INR=International Normalized Ratio, N=sample size, BMI=body mass index